169281 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
Traceability of cellular cycle anomalies targeting oncology and neurodegeneration
#602ELISA for VEGF
#603Compositions including triciribine and one or more platinum compounds and methods of use thereof
#604Monoclonal antibody against necrosis marker ERP29 and use thereof
#605Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof
#606Anti-hedgehog antibodies
#607Monoclonal antibody against necrosis marker PRDX4 and use thereof
#608Tumor suppressor designated TS10Q23.3
#609Compositions and Methods for Treating and Diagnosing Cancer
#610Diagnostic and Prognostic Markers for Cancer
#611PERINUCLEOLAR COMPARTMENT AS A CANCER MARKER
#612Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
#613APPARATUS AND METHOD FOR DETECTING TUMOR CELLS
#614Monoclonal antibodies against PCBP-1 antigens, and uses therefor
#615Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay
#616Endoglin antibodies
#617ANTI-NEOPLASTIC USES OF ARTEMIN ANTAGONISTS
#618IDENTIFICATION OF CANCER BIOMARKERS AND PHOSPHORYLATED PROTEINS
#619METHOD FOR CHARACTERIZING HOST IMMUNE FUNTION BY EX VIVO INDUCTION OF OFFENSIVE AND DEFENSIVE IMMUNE MARKERS
#620Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
#621CsPCNA isoform antibodies and uses thereof
#622DETERMINING SENSITIVITY OF CELLS TO B-RAF INHIBITOR TREATMENT BY DETECTING KRAS MUTATION AND RTK EXPRESSION LEVELS
#623Diagnostic and treatment for chronic and acute phase myeloid leukemia
#624Detection of dysplastic or neoplastic cells using anti-MCM3 antibodies
#625Compositions for Inhibiting Growth of Cancer Stem Cells
#626Methods for Assessing the Efficacy of Gemcitabine or Ara-C Treatment of Cancer Using Human Antigen R Levels
#627Anti-cMet antibody and its use for the detection and the diagnosis of cancer
#628NOVEL COMPOSITIONS AND METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF HUMAN CANCERS
#629DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES
#630BRM Expression and Related Diagnostics
#631ANTIBODIES AS A CANCER DIAGNOSTIC
#632METHOD FOR DIAGNOSING AND/OR TYPING RENAL CELL CARCINOMA
#633PSMCs As Modifiers of the RB Pathway and Methods of Use
#634Devices and methods of cell capture and analysis
#635Biomarker and Treatment for Cancer
#636METHODS FOR DETERMINING THE ONCOGENIC CONDITION OF CELL, USES THEREOF, AND METHODS FOR TREATING CANCER
#637HISTONE MODIFICATION PATTERNS FOR CLINICAL DIAGNOSIS AND PROGNOSIS OF CANCER
#638INTRATUMORAL GENE EXPRESSION LEVELS OF TP AND VEGF ARE ASSOCIATED WITH CLINICAL OUTCOMES IN RECTAL CANCER PATIENTS TREATED WITH 5-FLUOROURACIL AND PELVIC RADIATION
#639Compositions and methods for detecting cancer metastasis
#640Identification of a JAK2 mutation involved in vaquez polyglobulia
#641Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
#642METHODS AND USES INVOLVING GENETIC ABERRATIONS OF NAV3 AND ABERRANT EXPRESSION OF MULTIPLE GENES
#643Method for Determining the Cbl-b Expression
#644ANTI-HEDGEHOG ANTIBODIES
#645Method
#646DETECTION AND MODULATION OF CYTOCHROME C ACETYLATION
#647Chimeric RGMa polypeptides
#648Polypeptides for Specific Targeting to Otx2 Target Cells
#649METHODS OF MODULATING CELL DEATH BASED ON THE BIT1/AES REGULATORY PATHWAY
#650FRET-PROBES AND USE THEREOF
#651Method for identifying compounds for cancer therapy
#652Small molecule inhibitors of MUC1 and methods of identifying the same
#653Method for judging risk of cancer recurrence, computer program, and computer system
#654BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR KINASE INHIBITORS
#655Differential gene expression in physiological and pathological angiogenesis
#656POLYPEPTIDES AND POLYNUCLEOTIDES FOR ARTEMIN AND RELATED LIGANDS, AND METHODS OF USE THEREOF
#657Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide
#658Methods of treating a meiotic kinesin associated disease
#659GRADING OF BREAST CANCER
#660Method for prediction of the progression risk of tumors
#661IDENTIFICATION OF PREDICTIVE MARKERS OF RESPONSE TO DASATINIB IN HUMAN COLON CANCER
#662INTERFERON EPSILON (IFNE1) AS A MARKER FOR TARGETED CANCER THERAPY
#663Method for examining WT1-related disease
#664Methods and Compositions for Treating Carcinoma Stem Cells
#665BIOMARKERS AND METHODS FOR DETERMINING SENSITIVITY TO MICORTUBULE-STABILIZING AGENTS
#666Compositions and methods for the identification, assessment, prevention and therapy of human cancers
#667EXPRESSION OF KIR IN HUMAN CANCER CELLS AS A BIOMARKER FOR IMMUNO-ESCAPE AND CANCER METASTASIS
#668Methods for making cancer prognoses based on subcellular localization of biomarkers
#669FREE NGAL AS A BIOMARKER FOR CANCER
#670Endoglin antibodies
#671REPLICATION PROTEIN
#672Cancer vaccine composition
#673Methods of inhibiting tumor cell proliferation
#674FUNCTION AND REGULATION OF ADAMTS-1
#675Chd5 is a novel tumor suppressor gene
#676Method for cancer detection, diagnosis and prognosis
#677COPI MOLECULES AND USES THEREOF
#678Crystal structure of human JAK3 kinase domain complex and binding pockets thereof
#679Compositions and methods for immortalizing cells and screening for anti-cancer agents
#680PROLIFERATION MARKERS IN CLINICAL PRACTICE AND THEIR USE FOR BREAST CANCER PROGNOSIS OR DIAGNOSIS
#681Methods to identify USP1 deubiquitinating enzyme complex inhibitors
#682Marks as modifiers of the p53 pathway and methods of use
#683Antibodies against a cancer-associated epitope of variant NFKBIB and uses thereof
#684Nucleolin specific aptamer and use thereof
#685METHOD OF DIAGNOSIS AND AGENTS USEFUL FOR SAME
#686Antibodies against a cancer-associated epitope of variant HnRNPG and uses thereof
#687CANCER BIOMARKER AND USES THEREOF
#688Diagnosis method and treatment for cancer using liv21 proteins and E2F1/E2F4 biomarkers
#689HADHs as Modifiers of the p21 Pathway and Methods of Use
#690Use of an endoplasmin fragment and derivatives thereof as biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
#691Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
#692Methods of screening for modulators of cell proliferation and methods of diagnosing cell proliferation states
#693Anti-VEGF antibodies
#694Methods and compositions for identifying, classifying and monitoring subject having Bcl-2 family inhibitor-resistant tumors and cancers
#695In-vivo monitoring of circulating apoptotic cells
#696ADAMTS-7 AS A BIOMARKER FOR CANCERS OF EPITHELIAL ORIGIN
#697Gene specific to cancer and diagnosis kit using the same
#698Tubulin Isotype Screening in Cancer Therapy Using Halichondrin B Analogs
#699TUMOR SUPPRESSOR DESIGNATED TS10Q23.3
#700Chimeric DRG11-responsive (DRAGON) polypetides
#701COMPOSITIONS INCLUDING TRICIRIBINE AND ONE OR MORE PLATINUM COMPOUNDS AND METHODS OF USE THEREOF
#702Individualized cancer therapy
#703SCDs as modifiers of the p53 pathway and methods of use
#704METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TURMORGENICITY
#705EPIGENETIC BIOMARKERS FOR EARLY DETECTION, THERAPEUTIC EFFECTIVENESS, AND RELAPSE MONITORING OF CANCER
#706Anti-IGF antibodies
#707CANCER CELL IDENTIFICATION MARKER AND CANCER CELL PROLIFERATION INHIBITOR
#708Reagents and methods for use in cancer diagnosis, classification and therapy
#709Detection of dysplastic or neoplastic cells using anti-MCM6 antibodies
#710Disheveled PDZ modulators
#711Sox11 expression in malignant lymphomas
#712METHOD FOR PREVENTION OF TUMOR
#713Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
#714NOTCH mutations leading to increased receptor signaling
#715BRM EXPRESSION AND RELATED DIAGNOSTICS
#716ANTIBODY AND USES THEREOF
#717Perinucleolar compartment as a cancer marker
#718Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
#719Graded Expression of Snail as Marker of Cancer Development and DNA Damage-Based Diseases
#720Application of actin-binding protein to disease associated with cell motility
#721In vivo flow cytometry system and method
#722Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors
#723Circulating tumor cell assay
#724DIFFERENTIAL GENE EXPRESSION IN PHYSIOLOGICAL AND PATHOLOGICAL ANGIOGENESIS
#725B7-H1 AND SURVIVIN IN CANCER
#726Anti-hedgehog antibodies
#727NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND THEIR USE AS MARKERS FOR COLORECTAL CANCER
#728METHODS FOR ASSESSING SUITABILITY OF CANCER PATIENTS FOR TREATMENT WITH HISTONE DEACETYLASE INHIBITORS
#729Pharmacodiagnostic test targeting oncology and neurodegeneration
#730Screening method
#731Methods and Compositions Related to TR4
#732Method and probes for the detection of a tumor-specific fusion protein
#733In vitro method for identifying compounds for cancer therapy
#734Diagnostic tests and personalized treatment regimes for cancer stem cells
#735Cellular cycle anomalies for targeting oncology and neurodegeneration
#736POLYPEPTIDE HAVING ANTI-ANGIOGENIC ACTIVITY
#737Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
#738METHODS FOR IDENTIFYING NUCLEAR RECEPTOR/LIGAND COMBINATIONS FOR TARGETING BRAIN TUMOR STEM CELLS AND FOR THEIR USE
#739UHRF1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#740RUNX-MEDIATED ACTION OF NUCLEAR RECEPTORS AND UTILITIES THEREOF
#741IDENTIFICATION OF CANCER BIOMARKERS AND PHOSPHORYLATED PROTEINS
#742Drug resistance and methods of reversing
#743Prediction of Metastasis
#744Novel therapeutic targets in cancer
#745Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases
#746Identification of a JAK2 mutation in polycythemia vera
#747JAB1 as a prognostic marker and a therapeutic target for human cancer
#748DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE
#749Methods for Assessing Suitability of Cancer Patients for Treatment with Histone Deacetylase Inhibitors
#750Motif of the beclin protein which interacts with anti-apoptotic members of the Bcl-2 protein family, and uses
#751Grading of breast cancer
#752Diagnosis, prevention and treatment of cancer
#753Compositions and methods of treating cancer
#754PHARMACOGENOMIC MARKERS FOR PROGNOSIS OF SOLID TUMORS
#755Bone morphogenetic protein antagonist and uses thereof
#756Methods of modulating cell death based on the Bit-1/AES regulatory pathway
#757Sigma-2 Receptor, Method of Screening of Specific Ligands and Use of the Same in Diagnostic or Therapeutic Methods
#758Psmcs as Modifiers of the Rb Pathway and Methods of Use
#759METHOD FOR SCREENING FERTILITY AND NEW COMPOUNDS OR MOLECULES, USING CRT OR ERP57 TRANSLOCATION
#760Method of judging grade of malignancy of carcinoma cell using ATBF-1
#761Novel Integrin Ligand ITGL-TSP
#762Methods and Materials for Examining the P13k/Akt Pathway in Gliomas and Prostate Cancers
#763COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER
#764Compositions and methods for the identification, assessment, prevention and therapy of human cancers
#765Perinucleolar Compartment Markers for Cancer
#766PLKS as modifiers of the beta catenin pathway and methods of use
#767Adamts-7 as a Biomarker for Cancers of Epithelial Origin
#768PIK4CA as modifier of the Rac pathway and methods of use
#769Diagnostic, Prognostic, and Therapeutic Factor Smac/Diablo in Human Cancer
#770Method of Monitoring Anti-Tumor Activity of an Hdac Inhibitor
#771Diagnostics and Therapeutics for Diseases Associated with Arginyl Aminopeptidase (Aminopeptidase B)-Like 1 (Rnpepl1)
#772ELISA for VEGF
#773BIOMARKERS FOR SENSITIVITY OF PROLIFERATIVE DISEASES TO MTOR INHIBITORS
#774Automated Method for Detecting Cancers and High Grade Hyperplasias
#775Cspcna Isoform Antibodies and Uses Thereof
#776CELL REGULATORY GENES, ENCODED PRODUCTS, AND USES RELATED THERETO
#777AUTOMATED METHOD FOR DETECTING CANCERS AND HIGH GRADE HYPERPLASIAS
#778Method for modulating cell proliferation
#779Disheveled PDZ modulators
#780Inhibitors of USP1 Deubiquitinating Enzyme Complex
#781MARKs as Modifiers of the p53 Pathway and Methods of Use
#782Genetic products differentially expressed in tumors and the use thereof
#783Method for Determining Responsiveness to Chk1 Inhibitors
#784SCDs As Modifiers of the p53 Pathway and Methods of Use
#785Method for identifying agents which modulate cell growth or survival
#786Methods and compositions for detecting the activation states of multiple signal transducers in rare circulating cells
#787Identification of a JAK2 mutation in Polycythemia Vera
#788Methods for the treatment of cellular proliferative disorders
#789Methods for prognosis and treatment of solid tumors
#790Phosphorylated COP1 molecules and uses thereof
#791Methods for making cancer prognoses based on subcellular localization of biomarkers
#792COP1 molecules and uses thereof
#793Detection of dysplastic or neoplastic cells using anti-MCM2 antibodies
#794AgRM2 antigen
#795Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
#796Compositions and methods for detecting cancer and for inhibiting metastasis
#797Free NGAL as a biomarker for cancer
#798DETECTION OF PHOSPHORYLATED eIF2-alpha AS A DIAGNOSTIC TEST FOR EFFICACY AND SENSITIVITY OF TRANSLATION INITIATION INHIBITORS IN THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES
#799Biomarkers for sensitivity of proliferative diseases to mtor inhibitors
#800Antibodies as a cancer diagnostic
#801Method to determine whether a compound is a cellular GSTpi inhibitor
#802Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
#803Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
#804Method for assessing cancerous state
#805Method of reducing metal ions to elemental metal in the vicinity of an oxido-reductase enzyme
#806SALIVARY PROTEIN AND RNA FOR BREAST CANCER DETECTION
#807Identification of cancer biomarkers and phosphorylated pdroteins
#808Diagnostic application of mail
#809Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases
#810Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
#811Proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
#812NOTCH mutations leading to increased receptor signaling
#813Function and regulation of ADAMTS-1
#814Tumor suppressor designated TS10Q23.3
#815Tumor suppressor designated TS10q23.3
#816Hybridoma cell lines and monoclonal antibodies recognizing Prox1
#817Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
#818Predictive Methods For Cancer Chemotherapy
#819Novel Integrin Ligand ITGL-TSP
#820Novel Integrin Ligand ITGL-TSP
#821Prefoldin 4 in the treatment and diagnosis of cancer
#822Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor
#823Mapk7 as modifier of branching morphogenesis and methods of use
#824Interleukin-8 homologous polypeptides and therapeutic uses thereof
#825ANALYSIS OF TISSUE SAMPLES SURROUNDING MALIGNANCIES
#826Methods of identifying active BRM expression-promoting HDAC inhibitors
#827Identification of a JAK2 mutation involved in Vaquez Polyglobulia
#828Methods for detecting cancer and monitoring cancer progression
#829Dyrks as modifiersof the apc and axin pathways and methods of use
#830BIOMARKERS FOR BREAST CANCER
#831Method to detect lung cancer
#832Method of diagnosing cancer and method of judging cancer risk
#833Protein Arginine N-Methyltransferase 2 (PRMT-2)
#834BREAST CANCER PROGRESSION SIGNATURES
#835K203 gene and protein
#836HLJ1 gene expression
#837Methods for prognosis and treatment of solid tumors
#838Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative disease
#839Methods for identifying chemotherapeutic resistance in non-hematopoietic tumors
#840Interleukin-8 homologous polypeptides and therapeutic uses thereof
#841Methods for the treatment of cellular proliferative disorders
#842LIMKs as modifiers of p53 pathway and methods of use
#843Method for detecting loss of wild-type p53
#844Replication protein
#845Tubulin isotype screening in cancer therapy using halichondrin B analogs
#846Bladder matrix protein peptides and methods of detection of bladder cancer
#847Monoclonal antibody specific for PPAR gamma, hydridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same
#848In-vivo monitoring of circulating apoptotic cells
#849In vivo flow cytometry system and method
#850Materials and methods for treating cancer
#851Insulin-like growth factor system and cancer
#852Screening methods
#853ARF-BP1 as mediator of p53-dependent and independent tumor suppression and uses thereof
#854Protein biomarkers that distinguish prostate cancer from non-malignant cells
#855DRG11-responsive (DRAGON) gene and uses thereof
#856Treatment of transformed or infected biological cells
#857Crystal structure of human JAK3 kinase domain complex and binding pockets thereof
#858PRMTs as modifiers of the p53 pathway and methods of use
#859Cell regulatory genes, encoded products, and uses related thereto
#860Compositions and methods for treating and diagnosing cancer
#861Methods of inhibiting tumor cell proliferation
#862Diagnostic and therapeutic uses for prox 1
#863Method and probes for the detection of a tumor specific fusion protein
#864Oct-4 and GJIC expression as markers for adult human stem cells and cancer cell precursors
#865Chemosensitivity measurement using caspase activity
#866Novel integrin ligand ITGL-TSP
#867HADHs as modifiers of the p21 pathway and methods of use
#868HADHs as modifiers of the p21 pathway and methods of use
#869Chds as modifiers of the p53 pathway and methods of use
#870Methods and compositions for the detection of cervical cancer
#871Method for examining WT1-related disease
#872Tumor suppressor designated TS10q23.3
#873HX2004-6 polypeptide expressed in cancerous cells
#874Dgks as modifiers of the p53 pathwha and methods of use
#875Interleukin-8 homologous polypeptides and therapeutic uses thereof
#876Methods for diagnosing and treating neoplasias using nf-at transcriptions factors
#877JAB1 as a prognostic marker and a therapeutic target for human cancer
#878Determining prognosis of colon or breast cancer by measuring TTK expression
#879Diagnosis, prevention and treatment of cancer
#880Detection of colon or breast cancer by measuring TTK polypeptide expression
#881Detection of colon or breast cancer by measuring TTK polynucleotide expression
#882Methods of modulating cell death based on the Bit1/AES regulatory pathway
#883Nucleic acids having expression differentials between hepatoblastoma and normal liver
#884Methods of inhibiting tumor cell proliferation
#885Methods of monitoring and modulating LKB1 activity and its downstream targets
#886Triosephosphate isomerase directed diagnostics and therapeutics for multidrug resistant neoplastic disease
#887Methods of treating cancer
#888Monoclonal antibody to human line-1 ORF2 protein and method for early detection of transforming cells in pre-neoplastic tissues of a human subject
#889ER-stress inducing compounds and methods of use thereof